enVVeno Medical (NVNO) Accumulated Depreciation (2017 - 2025)

enVVeno Medical's Accumulated Depreciation history runs 9 years deep, the most recent figure standing at $1.4 million for Q4 2025.

• On a quarterly basis, Accumulated Depreciation rose 10.82% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 10.82% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 10.82% from the prior year.
• Accumulated Depreciation rose to $1.4 million in Q4 2025 per NVNO's latest filing, from $1.3 million in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $1.4 million in Q4 2025 and bottomed at $515521.0 in Q1 2021.
• The 5-year median for Accumulated Depreciation is $903000.0 (2023), against an average of $938505.4.
• Across the five-year window, Accumulated Depreciation soared 33.46% in 2022 and gained 10.82% in 2025, its largest moves.
• Year by year, Accumulated Depreciation stood at $637000.0 in 2021, then surged by 33.28% to $849000.0 in 2022, then increased by 25.91% to $1.1 million in 2023, then rose by 17.59% to $1.3 million in 2024, then advanced by 10.82% to $1.4 million in 2025.
• Per Business Quant, the three latest NVNO Accumulated Depreciation figures stand at $1.4 million (Q4 2025), $1.3 million (Q1 2025), and $1.3 million (Q4 2024).